1. Ramadan fasting model modulates biomarkers of longevity and metabolism in male obese and non-obese rats
- Author
-
Abeer Abdallah Alasmari, Maha H. Alhussain, Abdulrahman Saleh Al-Khalifah, Noura Mohammed Alshiban, Rawan Alharthi, Nouf M. Alyami, Hesham S. Alodah, Mohammed F. Alahmed, Bayan A. Aljahdali, and Ahmed S. BaHammam
- Subjects
Fasting ,Ramadan ,Longevity ,Metabolism ,Obesity ,Aging ,Medicine ,Science - Abstract
Abstract The health advantages of Ramadan fasting, a time-restricted eating from dawn to dusk, have garnered attention. Nevertheless, prior observational studies have found inconsistent findings because of challenges regulating variables such as sleep patterns, dietary habits, and physical activity. This study sought to investigate the impact of the Ramadan fasting model (RFM) on longevity and metabolic biomarkers in obese and non-obese rats. For 12 weeks, 48 male Wistar albino rats were separated into two groups and fed either a standard or a high-fat diet (HFD). During the final four weeks, rats in each group were separated into four subgroups to investigate the effect of RFM with/without training (on Treadmill) or glucose administration on the biomarkers of interest. The HFD groups subjected to RFM had significantly lower Insulin-like growth factor 1 (IGF-1) and mechanistic target of rapamycin (mTOR) serum, whereas AMPK, anti-inflammatory, and antioxidative stress serum levels were significantly higher. All groups reported decreased serum levels of Interleukin-6 (IL-6) and Tumor Necrosis Factor-alpha (TNF-α) compared to the HFD control group. Furthermore, the Real-Time Quantitative Polymerase Chain Reaction (RT-qPCR) results indicated a significant elevation in the TP53 gene expression in groups subjected to RFM. The data indicate that RFM can improve longevity and metabolic biomarkers and reduce pro-inflammation and oxidative stress. Also, RFM improves anti-inflammatory and antioxidant markers in HFD-induced obese rats.
- Published
- 2024
- Full Text
- View/download PDF